PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 3.5M 7M 10.5M FY14: 852 FY15: 213 FY16: 0 FY17: 0 FY18: 0 FY19: 345.7K FY20: 9M FY21: 2.1M FY22: 1.6M FY23: 2.4M FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23

Gross Profit Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY18: 0 FY19: -1.7M FY20: 2M FY21: 540.6K FY22: 396.5K FY23: 1.1M FY18 FY19 FY20 FY21 FY22 FY23

Operating Income Annual

-12M -8M -4M 0 4M 8M 12M FY14: -420.3K FY15: -389.3K FY16: -1.6M FY17: -3.1M FY18: -2.4M FY19: -10.7M FY20: -5.3M FY21: -5.9M FY22: -5.7M FY23: -5.5M FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23

Net Income Annual

-10.5M -7M -3.5M 0 3.5M 7M 10.5M FY14: -296.6K FY15: -358K FY16: -1.6M FY17: -3.9M FY18: -4.3M FY19: -10M FY20: -5.2M FY21: -4.8M FY22: -9.1M FY23: -8M FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23

Cost of Revenue Annual

0 2.5M 5M 7.5M FY18: 0 FY19: 1.9M FY20: 7M FY21: 1.5M FY22: 1.2M FY23: 1.3M FY18 FY19 FY20 FY21 FY22 FY23

Operating Cash Flow Annual

-9M -6M -3M 0 3M 6M 9M FY14: -399.6K FY15: -640K FY16: -891K FY17: -1.2M FY18: -465.8K FY19: -5.7M FY20: -7.6M FY21: -3.9M FY22: -2.4M FY23: -1.5M FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23

Free Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY14: -405.7K FY15: -640K FY16: -892.2K FY18: -465.8K FY19: -6.3M FY20: -10.8M FY21: -4.1M FY22: -2.6M FY23: -1.6M FY14 FY15 FY16 FY18 FY19 FY20 FY21 FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY21: 16.9M FY22: 14.9M FY23: 16.6M FY21 FY22 FY23

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q4 '14: -0.02 Q1 '15: -0.16 Q2 '15: -0.38 Q3 '15: -0.38 Q4 '15: -0.42 Q1 '16: -0.83 Q2 '16: -0.64 Q3 '16: -0.64 Q4 '17: -0.92 Q1 '18: -1.14 Q2 '18: -1.24 Q3 '18: -1.55 Q4 '18: -0.91 Q1 '19: -0.74 Q2 '19: -0.67 Q3 '19: -0.39 Q4 '19: -0.32 Q1 '20: -0.31 Q2 '20: -0.22 Q3 '20: -0.39 Q4 '20: -0.39 Q1 '21: -0.31 Q2 '21: -0.35 Q3 '21: -0.27 Q4 '21: -0.24 Q1 '22: -0.45 Q2 '22: -0.58 Q3 '22: -0.62 Q4 '22: -0.62 Q1 '23: -0.55 Q2 '23: -0.53 Q3 '23: -0.48 Q4 '23: -0.49 Q1 '24: -0.46 Q3 '15 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.